Sanaa El Marsafy

BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity.

Armand Bensussan, Éliane Gluckman, Sanaa El Marsafy et al. · Proceedings of the National Academy of Sciences · 1994 · 53 citations · Full text

Cell Therapy, Lymphocyte Development, Immunology +20

Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia

Ivan Sloma, Maria Teresa Mitjavila‐Garcia, Olivier Féraud et al. · Experimental Hematology · 2017 · 17 citations

Hematological Malignancy, Chromatin, Mutant Subclone Development +7

Study of cord blood natural killer cell suppressor activity

Sanaa El Marsafy, Christine Dosquet, M‐C. Coudert et al. · European Journal Of Haematology · 2001 · 16 citations

Cell Therapy, Lymphocyte Development, Immunology +16

Mesenchymal Stem Cells: Pivotal Players in Hematopoietic Stem Cell Microenvironment

Sanaa El Marsafy · Journal of Stem Cell Research & Therapy · 2014 · 11 citations · Full text

Modifications of leukemic blast cells induced by in vivo high-dose recombinant interleukin-2.

Daniel Olive, Hérvè Chambost, Danielle Sainty et al. · PubMed · 1994 · 10 citations